Breath Test for Tuberculosis

About Menssana Research

Menssana Research is a long-standing private diagnostics company pioneering breath-based testing for early disease detection. Its core platform analyzes volatile organic compounds (VOCs) to identify biomarkers for conditions like lung cancer, breast cancer, tuberculosis, and influenza. The company has generated a substantial body of peer-reviewed research over decades, with recent publications in 2024 focusing on breast cancer prediction, indicating active development of its pipeline toward clinical application. Menssana operates in the large and growing market for non-invasive, point-of-care diagnostics, aiming to provide rapid, low-cost screening tools.

Therapeutic Areas